Optimer Pharmaceuticals, Inc. (OPTR) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents	72.84M
Short-term investments	4.66M
Research grant and other receivables
Inventory	26.92M
Prepaid expenses and other current assets	1.94M
Total current assets	114.96M
Property and equipment, net	4.33M
Long-term investments	0
Other assets	1.06M
Total assets	121.25M
Current liabilities:
Accounts payable	2.73M
Accrued expenses	27.25M
Total current liabilities	30.09M
Deferred rent	1.19M
Stockholders' equity:
Preferred stock, par value $0.001, 10,000,000 shares authorized, no shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	0
Common stock, $0.001 par value, 75,000,000 shares authorized, 46,602,501 shares and 39,278,965 shares issued and outstanding at June 30, 2011 and December 31, 2010 respectively	48.87K
Additional paid-in capital	398.81M
Accumulated other comprehensive income	398.48K
Accumulated deficit	-310.18M
Total Optimer Pharmaceuticals, Inc. stockholders' equity	89.08M
Noncontrolling interest
Total stockholders' equity
Total liabilities and stockholders' equity	121.25M

Entities mentioned with OPTR